227 related articles for article (PubMed ID: 31714057)
1. Once Daily Pregabalin Eye Drops for Management of Glaucoma.
Ibrahim MM; Maria DN; Mishra SR; Guragain D; Wang X; Jablonski MM
ACS Nano; 2019 Dec; 13(12):13728-13744. PubMed ID: 31714057
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
3. Influence of the calcium voltage-gated channel auxiliary subunit (CACNA2D1) absence on intraocular pressure in mice.
Lankford L; Maddala R; Jablonski MM; Rao PV
Exp Eye Res; 2024 Apr; 241():109835. PubMed ID: 38373629
[TBL] [Abstract][Full Text] [Related]
4. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
[TBL] [Abstract][Full Text] [Related]
5. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
[TBL] [Abstract][Full Text] [Related]
6. Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.
Germann SE; Matheis FL; Rampazzo A; Burger D; Roos M; Spiess BM
Equine Vet J; 2008 Nov; 40(7):662-5. PubMed ID: 18487097
[TBL] [Abstract][Full Text] [Related]
7. Cubogel as potential platform for glaucoma management.
Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM
Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004
[TBL] [Abstract][Full Text] [Related]
8. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
9. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma.
Giuffrida S; Bucolo C; Drago F
J Ocul Pharmacol Ther; 2003 Dec; 19(6):527-34. PubMed ID: 14733710
[TBL] [Abstract][Full Text] [Related]
10. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D
Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821
[TBL] [Abstract][Full Text] [Related]
11. Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study.
Gautam N; Kesavan K
Curr Eye Res; 2021 Dec; 46(12):1844-1852. PubMed ID: 34176380
[No Abstract] [Full Text] [Related]
12. Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys.
Tian B; Wang RF; Podos SM; Kaufman PL
Arch Ophthalmol; 2004 Aug; 122(8):1171-7. PubMed ID: 15302658
[TBL] [Abstract][Full Text] [Related]
13. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
J Oleo Sci; 2010; 59(8):423-30. PubMed ID: 20625234
[TBL] [Abstract][Full Text] [Related]
14. A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
Prasanna G; Ferrara L; Adams C; Ehara T; Li B; Yang L; Xiang C; Ng CTH; Kim S; Towler C; Topley T; McAllister C; Ghosh M; Newton R; Stacy R; Rice DS; Mogi M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1704-1716. PubMed ID: 29610853
[TBL] [Abstract][Full Text] [Related]
15. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
Gelatt KN; MacKay EO
Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
[TBL] [Abstract][Full Text] [Related]
16. DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment.
Lancina MG; Wang J; Williamson GS; Yang H
Mol Pharm; 2018 Jul; 15(7):2883-2889. PubMed ID: 29767982
[TBL] [Abstract][Full Text] [Related]
17. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
18. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
Kouchak M; Mahmoodzadeh M; Farrahi F
AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
[TBL] [Abstract][Full Text] [Related]
19. Novel ofloxacin-loaded microemulsion formulations for ocular delivery.
Üstündag-Okur N; Gökçe EH; Eğrilmez S; Özer Ö; Ertan G
J Ocul Pharmacol Ther; 2014 May; 30(4):319-32. PubMed ID: 24367973
[TBL] [Abstract][Full Text] [Related]
20. Effects of topical ethacrynic acid ointment vs timolol on intraocular pressure in glaucomatous monkey eyes.
Wang RF; Podos SM; Serle JB; Lee PY; Neufeld AH; Deschenes R
Arch Ophthalmol; 1994 Mar; 112(3):390-4. PubMed ID: 8129666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
